• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (PLCH2), Truncated

ACP21093

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP21093 Target NamePLCH2
FormLyophilized powderExpression SystemCustom Production. Please inquire and provide the desire expression system.
Protein LengthPartialPurity>85% (SDS-PAGE)
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDO75038
Background Information
  • Uniprot Id

    O75038

  • Target Species

    Human

  • Target Name

    PLCH2

  • Target Full Name

    1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2

  • Target Function

    The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes. This phospholipase activity is very sensitive to calcium. May be important for formation and maintenance of the neuronal network in the postnatal brain.

  • Target Subcellular Location

    Cytoplasm. Cell membrane.

  • Target Tissue Specificity

    Expressed in retina and kidney.

  • Target Synonyms

    1-phosphatidylinositol-4; 5-bisphosphate phosphodiesterase eta-2; KIAA0450; Phosphoinositide phospholipase C-eta-2; Phosphoinositide phospholipase C-like 4; Phospholipase C-eta-2; Phospholipase C-like protein 4; PLC-eta2; PLC-L4; Plch2; PLCH2_HUMAN; PLCL4

Inquire Recombinant Human 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase eta-2 (PLCH2), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification